These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 26281146

  • 1. Early Intervention in Living Kidney Transplantation Based on Dynamic Monitoring of Donor Specific Antibodies.
    Chen Y, Li LY, Lou XY, Wang H, Zhang L, Zhu YH.
    Clin Transpl; 2014; ():205-8. PubMed ID: 26281146
    [Abstract] [Full Text] [Related]

  • 2. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J, Xue W, Qing X, Jing X, Hou J, Tian X, Guo Q, He X, Cai J.
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [Abstract] [Full Text] [Related]

  • 3. De novo donor specific antibodies and patient outcomes in renal transplantation.
    DeVos JM, Patel SJ, Burns KM, Dilioglou S, Gaber LW, Knight RJ, Gaber AO, Land GA.
    Clin Transpl; 2011; ():351-8. PubMed ID: 22755430
    [Abstract] [Full Text] [Related]

  • 4. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C, Willicombe M, Brookes PA, Santos-Nunez E, Bajaj R, Cook T, Roufosse C, Taube D, Warrens AN.
    Transplantation; 2013 Jan 27; 95(2):341-6. PubMed ID: 23197178
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of post kidney transplant de novo DSA in otherwise stable grafts.
    Cooper JE, Gralla J, Chan L, Wiseman AC.
    Clin Transpl; 2011 Jan 27; ():359-64. PubMed ID: 22755431
    [Abstract] [Full Text] [Related]

  • 6. High-Dose Intravenous Immunoglobulin Therapy for Donor Specific Antibodies in Kidney Transplant Recipients with Acute and Chronic Graft Dysfunction: Updates on Previously Reported Cohorts.
    Alfonso J, Gralla J, Klem P, Chan L, Wiseman AC, Cooper JE.
    Clin Transpl; 2014 Jan 27; ():161-70. PubMed ID: 26281141
    [Abstract] [Full Text] [Related]

  • 7. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
    Zhu D, Qi G, Tang Q, Li L, Yang C, Lin M, Wu B, Xu M, Cai J, Zhu T, Rong R.
    Clin Transpl; 2014 Jan 27; ():215-21. PubMed ID: 26281148
    [Abstract] [Full Text] [Related]

  • 8. Targeted monitoring of donor-specific HLA antibodies following renal transplantation.
    Almeshari K, Pall A, Chaballout A, Elgamal H, Almana H, Alzayer F, Abaalkhail N, Altalhi M.
    Clin Transpl; 2011 Jan 27; ():395-400. PubMed ID: 22755437
    [Abstract] [Full Text] [Related]

  • 9. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS, Vasilescu R, Tanriover B, Coppleson Y, Rekhtman Y, Hardy MA, Dube G, Crew RJ, Ratner LE, Cohen DJ, Mohan S.
    Transplantation; 2014 Mar 27; 97(6):642-7. PubMed ID: 24637863
    [Abstract] [Full Text] [Related]

  • 10. A report of the epidemiology of de novo donor-specific anti-HLA antibodies (DSA) in "low-risk" renal transplant recipients.
    Rebellato LM, Everly MJ, Haisch CE, Ozawa M, Briley KP, Parker K, Catrou PG, Bolin P, Kendrick WT, Kendrick SA, Harland RC.
    Clin Transpl; 2011 Mar 27; ():337-40. PubMed ID: 22755428
    [Abstract] [Full Text] [Related]

  • 11. Improved Long-Term Survival in Kidney Transplant Recipients with Donor-Specific HLA Antibodies After Mycophenolic Acid Escalation.
    Rebellato LM, Parker K, Everly MJ, Briley KP, Kendrick W, Kendrick S, Haisch CE, Terasaki PI, Bolin P.
    Clin Transpl; 2014 Mar 27; ():137-42. PubMed ID: 26281138
    [Abstract] [Full Text] [Related]

  • 12. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.
    Clin Biochem; 2013 Oct 27; 46(15):1389-93. PubMed ID: 23726814
    [Abstract] [Full Text] [Related]

  • 13. Influence of de novo donor-specific antibody on early renal allograft function recovery.
    Zheng J, Xue W, Jing X, Hou J, Tian X, Tian P, Ding X, Pan X, Yan H, Feng X, Xiang H, Li Y, Ding C.
    Ren Fail; 2015 Apr 27; 37(3):462-8. PubMed ID: 25697229
    [Abstract] [Full Text] [Related]

  • 14. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.
    Amico P, Hönger G, Mayr M, Steiger J, Hopfer H, Schaub S.
    Transplantation; 2009 Jun 15; 87(11):1681-8. PubMed ID: 19502960
    [Abstract] [Full Text] [Related]

  • 15. The Role of HLA Antibodies in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhang X, Wang J, Zhou Z, Zhang Y, Liu H, Tong C, Yu C, Lu Y, Zhao Y, Xiong M, Zhou JR, Juan S, Liu DY, Wei Z, Zhang J, Wu T, Lu DP.
    Clin Transpl; 2014 Jun 15; ():245-50. PubMed ID: 26281152
    [Abstract] [Full Text] [Related]

  • 16. Effects of Two Preemptive Post-transplant Desensitization Regimens Upon Renal Allograft Survival and DSA Elaboration.
    Kimball PM, McDougan FA, King A.
    Clin Transpl; 2014 Jun 15; ():197-203. PubMed ID: 26281145
    [Abstract] [Full Text] [Related]

  • 17. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation.
    Thiyagarajan UM, Bagul A, Frost J, Horsburgh T, Nicholson ML.
    Transplant Proc; 2012 Jun 15; 44(5):1231-5. PubMed ID: 22663991
    [Abstract] [Full Text] [Related]

  • 18. A novel post-transplant alloantibody surveillance and intervention strategy that improves graft outcomes in sensitized renal transplant recipients.
    Kimball PM, King A.
    Clin Transpl; 2011 Jun 15; ():369-72. PubMed ID: 22755433
    [Abstract] [Full Text] [Related]

  • 19. Impact of HLA antibodies on graft survival in long-term renal recipients with functional grafts.
    Zeng Y, Liu Z, Liu Y, Fan Y, Guo Y, Qiu J.
    Urol Int; 2014 Jun 15; 92(3):328-33. PubMed ID: 24480999
    [Abstract] [Full Text] [Related]

  • 20. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D, Bach C, Staudner C, Böger CA, Bergler T, Banas B, Spriewald BM.
    Nephrol Dial Transplant; 2017 Apr 01; 32(4):730-737. PubMed ID: 28339671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.